Meta-analysis of the occurrence of hepatocellular carcinoma after the treatment of entecavir and tenofovir for chronic hepatitis B

Tenofovir and Entecavir are recommended as the first-line medicine of treatment for chronic hepatitis B. The occurrence of hepatocellular carcinoma after the treatment of chronic hepatitis B is a major problem. For the time being it is still unclear whether there remains a difference in risk correla...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Kaiyue, Cheng, Huizhen, Wang, Haiyan, Guo, Yueping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907921/
https://www.ncbi.nlm.nih.gov/pubmed/36820558
http://dx.doi.org/10.1097/MD.0000000000032894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907921/
https://www.ncbi.nlm.nih.gov/pubmed/36820558
http://dx.doi.org/10.1097/MD.0000000000032894

Ejemplares similares